Clinical Trials Directory

Trials / Unknown

UnknownNCT05185362

Epidemiology of Pecan Nut Allergy

Retrospective Study on Pecan Nut Allergy Epidemiology

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
5 Years – 70 Years
Healthy volunteers
Accepted

Summary

IgE-mediated food allergy can manifest with reactions ranging from hives to anaphylactic shock. The diagnosis is based on the confirmation of sensitization to the food allergen by skin tests (prick) and the determination of specific IgE directed against the food source and molecular allergens. The gold standard remains the oral provocation test, which is performed in a hospital environment. Once the diagnosis is made, an elimination diet is still considered as the cornerstone of treatment for most food allergies. While some allergies, such as cow's milk or egg, tend to resolve spontaneously, others, such as allergy to pecan nuts, show a tendency to be persistent. In addition, pecan allergy is often characterized by potentially serious clinical reactions, compared to other foods, which can even be life threatening. In our clinical practice, the investigators found that patients with allergies to pecan nuts often present with severe hypersensitivity reactions when challenged orally to this food. Beyond this information, there are few studies regarding pecans. The investigators decided to retrospectively evaluate the results of oral food challenge and of the allergy work-up in our patients sensitized and allergic to pecan nuts, to better understand the current epidemiology of such food allergy.

Conditions

Timeline

Start date
2021-11-01
Primary completion
2022-01-01
Completion
2022-04-01
First posted
2022-01-11
Last updated
2022-01-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05185362. Inclusion in this directory is not an endorsement.